{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:10:33Z","timestamp":1780409433636,"version":"3.54.1"},"reference-count":43,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2022,3,4]]},"DOI":"10.1080\/17446651.2022.2044789","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T10:35:15Z","timestamp":1645526115000},"page":"99-109","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Osilodrostat oral tablets for adults with Cushing\u2019s disease"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1752-1641","authenticated-orcid":false,"given":"Marianna","family":"Martino","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences (DISCLIMO), Universit\u00e0 Politecnica Delle Marche, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nairus","family":"Aboud","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences (DISCLIMO), Universit\u00e0 Politecnica Delle Marche, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Lucchetti","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences (DISCLIMO), Universit\u00e0 Politecnica Delle Marche, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmaria","family":"Salvio","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences (DISCLIMO), Universit\u00e0 Politecnica Delle Marche, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6204-3423","authenticated-orcid":false,"given":"Giorgio","family":"Arnaldi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences (DISCLIMO), Universit\u00e0 Politecnica Delle Marche, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0125"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030871"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0612"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1818"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0062"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0265"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2734"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-015-0692-z"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa778"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.157271"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.029892"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12051"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0340-9"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs388"},{"key":"cit0015","unstructured":"FDA approves new treatment for adults with cushing\u2019s disease | FDA [Internet]. 2020 Mar 06 cited 2021 Oct 27]. Available from 2021 Oct 27: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-treatment-adults-cushings-disease."},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01277-0"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00648"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1021\/ml400324c"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(10)60584-0"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-016-0033-9"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2117"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00217"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30240-0"},{"key":"cit0024","unstructured":"Assessment report - Isturisa - European medicines agency [Internet]. 2019 cited 2021 Oct 27]. Abailable from 2021 Oct 27: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/isturisa"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-017-0497-0"},{"issue":"1","key":"cit0026","first-page":"SAT","volume":"3","author":"Breitschaft A","year":"2019","journal-title":"J Endocr Soc"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ19-0617"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0557"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2015.05.004"},{"key":"cit0030","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/edrv\/38.supp.1","volume":"38","author":"Pivonello R","year":"2017","journal-title":"Endocr Rev"},{"key":"cit0031","unstructured":"Pharmacokinetic (PK), pharmacodynamic (PD) and tolerability of osilodrostat in pediatric patients with Cushing\u2019s disease - clinicaltrials.gov [Internet]. 2018 cited 2022 feb 13]. Available from 2022 feb 13: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03708900"},{"key":"cit0032","unstructured":"Roll-over study in patients with endogenous Cushing\u2019s syndrome for LCI699 - CLINICALTRIALS.gov [Internet]. 2018 cited 2022 feb 13]. Available from 2022 feb 13: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03606408"},{"key":"cit0033","unstructured":"Efficacy and Safety Evaluation of Osilodrostat in Cushing\u2019s Disease - ClinicalTrials.gov [Internet]. 2016 cited 2021 Oct 27]. Available from 2021 Oct 27: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02697734."},{"key":"cit0034","volume":"63","author":"Pivonello R","year":"2019","journal-title":"Endocr Abstr"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0514"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0358"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1328"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01097-1"},{"key":"cit0039","first-page":"144","volume":"1","author":"Grossman AB","year":"2017","journal-title":"J Endocr Soc"},{"issue":"1","key":"cit0040","first-page":"OR16","volume":"3","author":"Biller BM","year":"2019","journal-title":"J Endocr Soc"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab048.1055"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0467"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00823"}],"container-title":["Expert Review of Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17446651.2022.2044789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T17:22:48Z","timestamp":1649870568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17446651.2022.2044789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3,4]]}},"alternative-id":["10.1080\/17446651.2022.2044789"],"URL":"https:\/\/doi.org\/10.1080\/17446651.2022.2044789","relation":{},"ISSN":["1744-6651","1744-8417"],"issn-type":[{"value":"1744-6651","type":"print"},{"value":"1744-8417","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iere20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iere20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}